Cannabis Industry Outlook 2027|by CBD Library / Cannabis Newsletter

Cannabis in 2027, as seen by the people who shape it.

We asked twelve leading voices in policy, medicine, investment and cultivation for three predictions about the year ahead, and the reasoning behind each one.

Experts
12
Sectors
4
Countries
11
Published
December 2026

Key themes

What 36 predictions add up to: where the panel agrees, and where it splits.

Read the full analysis
  1. Evidence replaces argument

    Pilot markets and large clinical trials will give regulators real data for the first time.

    9 of 12 experts
  2. Medical-first becomes the global default

    New markets will open through medicine and exports, not adult-use retail.

    8 of 12 experts
  3. Capital consolidates before it expands

    Fewer, larger operators. Mergers will outpace new entrants.

    7 of 12 experts
  4. Products must prove their claims

    CBD and minor cannabinoids will compete on evidence and quality, not marketing.

    6 of 12 experts
  5. The open question: US rescheduling

    The panel’s sharpest split. Five expect real change in 2027; seven do not.

    5 vs 7 divided

The experts

Four sectors. Three predictions each. One year ahead.

Twelve experts, eleven countries

Cannabis is regulated differently in every market. This year’s outlook draws on five regions.

How we chose the panel

No expert paid to appear, and every financial interest is disclosed on their page.

Read our methodology
  1. Ten years or more in the fieldEvery panellist has worked in cannabis or an adjacent profession for at least a decade.
  2. Balanced by sector and regionThree experts per sector, drawn from five regions, so no single market dominates the outlook.
  3. Predictions submitted independentlyEach expert sends three predictions before their interview, without seeing anyone else’s.
  4. Reviewed one year laterAt the end of 2027 we will publish how each prediction played out.

Published by

Cannabis Industry Outlook 2027 is an independent editorial project by two cannabis publications.

About the project

CBD Library

An independent resource on cannabinoid science, products and regulation.

Visit CBD Library

Cannabis Newsletter

A daily briefing on the global cannabis industry for professionals and investors.

Visit Cannabis Newsletter

Get in touch.

For expert nominations, interview requests, partnerships and press enquiries.

contact@example.com →

We reply within three business days.